MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Pharmaceutical Development and Clinical Trials (Facts & Figures)
Parents
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Pharmaceuticals, Clinical Trials, CROs, CDMOs & Pharmacovigilance
Children
"more than 2,000 new medicines are in development, including 646 medicines for cancer, 146 for heart disease and stroke, 77 for
*2012: Pharmaceutical: Market Leaders
*Pioneers: Clinical Trials Design, Management & Pharmacovigilance
>13% FDA success rate from preclinical cancer drug candidate to FDA approval
2003: Blockbuster Biotechnology = 7 (2003)
2003: Blockbuster products ($1billion in sales) = 65 (2003)
2003: Blockbuster products ($2billion in sales) = 25 (2003)
2004: Blockbuster Biotechnology = 11 (2004)
2004: Blockbuster products ($1billion in sales) = 82 (2004)
2004: Blockbuster products ($2billion in sales) = 34 (2004)
2005: 5,830 products submitted to FDA for Approval (2005)
2005: Recent Drug Launches (2005)
2007: Blockbuster growth projected at 100 in 2007
2012: Top 5: Silicon Valley life science patent recipients - Silicon Valley (2012)
2013: Top 15 Drug Launch Superstars
2015: Biopharma's 10 highest-paid heads of R&D
2015: The top 20 highest-paid biopharma CEOs
2018: AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
2018: The top 15 pharma companies by 2017 revenue
24 large pharmaceutical companies report spending 0.3% of sales on post drug approval (Mar06 Health Affairs)=$800m
80% to 90% of the industry collects information using three-ring binders
Annual spending on outsourced research globally has grown 20% to 30% over the past decade
Between 8,000 and 10,000 clinical trials a year put data on paper before transcribing it to electronic form
Blockbuster distribution is 20% Biotechnology, 80% Non-Biotechnology
In about 20% of cases the clinical research work is outsourced to contract research organizations
Only 10% to 20% of the drug industry uses EDC.
That increase is expected to slow to 10%, says Dr. Hugo Stephenson, president of Strategic Research Services at Quintiles.
Jumps
Architects: Medical Counterfeiting, Product Tracking and Anti- Fraud